Works matching AU Garon, Edward B.

Results: 45
    1

    RELAY, Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients with Untreated, Epidermal Growth Factor Receptor Mutation-Positive, Metastatic Non-Small-Cell Lung Cancer: Safety Profile and Manageability.

    Published in:
    Drug Safety, 2022, v. 45, n. 1, p. 45, doi. 10.1007/s40264-021-01127-2
    By:
    • Nadal, Ernest;
    • Horinouchi, Hidehito;
    • Shih, Jin-Yuan;
    • Nakagawa, Kazuhiko;
    • Reck, Martin;
    • Garon, Edward B.;
    • Wei, Yu-Feng;
    • Kollmeier, Jens;
    • Frimodt-Moller, Bente;
    • Barrett, Emily;
    • Lipkovich, Olga;
    • Visseren-Grul, Carla;
    • Novello, Silvia
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Patient-reported outcomes in RELAY, a phase 3 trial of ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small-cell lung cancer.

    Published in:
    Current Medical Research & Opinion, 2020, v. 36, n. 10, p. 1667, doi. 10.1080/03007995.2020.1808781
    By:
    • Yoh, Kiyotaka;
    • Atagi, Shinji;
    • Reck, Martin;
    • Garon, Edward B.;
    • Ponce Aix, Santiago;
    • Moro-Sibilot, Denis;
    • Winfree, Katherine B.;
    • Frimodt-Moller, Bente;
    • Zimmermann, Annamaria;
    • Visseren-Grul, Carla;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    13

    Detection of EGFR Mutations in cfDNA and CTCs, and Comparison to Tumor Tissue in Non-Small-Cell-Lung-Cancer (NSCLC) Patients.

    Published in:
    Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.572895
    By:
    • Liu, Haiyan E.;
    • Vuppalapaty, Meghah;
    • Wilkerson, Charles;
    • Renier, Corinne;
    • Chiu, Michael;
    • Lemaire, Clementine;
    • Che, James;
    • Matsumoto, Melissa;
    • Carroll, James;
    • Crouse, Steve;
    • Hanft, Violet R.;
    • Jeffrey, Stefanie S.;
    • Di Carlo, Dino;
    • Garon, Edward B.;
    • Goldman, Jonathan;
    • Sollier, Elodie
    Publication type:
    Article
    14
    15

    Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs.

    Published in:
    JAMA: Journal of the American Medical Association, 2014, v. 311, n. 19, p. 1998, doi. 10.1001/jama.2014.3741
    By:
    • Kris, Mark G.;
    • Johnson, Bruce E.;
    • Berry, Lynne D.;
    • Kwiatkowski, David J.;
    • Iafrate, A. John;
    • Wistuba, Ignacio I.;
    • Varella-Garcia, Marileila;
    • Franklin, Wilbur A.;
    • Aronson, Samuel L.;
    • Pei-Fang Su;
    • Yu Shyr;
    • Camidge, D. Ross;
    • Sequist, Lecia V.;
    • Glisson, Bonnie S.;
    • Khuri, Fadlo R.;
    • Garon, Edward B.;
    • Pao, William;
    • Rudin, Charles;
    • Schiller, Joan;
    • Haura, Eric B.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22

    A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 3, p. 266, doi. 10.1016/j.cllc.2024.03.003
    By:
    • Garon, Edward B.;
    • Byoung Chul Cho;
    • Luft, Alexander;
    • Alatorre-Alexander, Jorge;
    • Geater, Sarayut Lucien;
    • Dmytro Trukhin;
    • Sang-We Kim;
    • Ursol, Grygorii;
    • Hussein, Maen;
    • Louise Lim, Farah;
    • Cheng-Ta Yang;
    • Araujo, Luiz Henrique;
    • Haruhiro Saito;
    • Reinmuth, Niels;
    • Kohlmann, Milena;
    • Lowery, Caitlin;
    • Mann, Helen;
    • Peters, Solange;
    • Mok, Tony S.;
    • Johnson, Melissa L.
    Publication type:
    Article
    23
    24
    25
    26

    Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer (MYSTIC).

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. 301, doi. 10.1016/j.cllc.2021.02.010
    By:
    • Garon, Edward B.;
    • Cho, Byoung Chul;
    • Reinmuth, Niels;
    • Lee, Ki Hyeong;
    • Luft, Alexander;
    • Ahn, Myung-Ju;
    • Robinet, Gilles;
    • Le Moulec, Sylvestre;
    • Natale, Ronald;
    • Schneider, Jeffrey;
    • Shepherd, Frances A.;
    • Garassino, Marina Chiara;
    • Geater, Sarayut Lucien;
    • Szekely, Zsolt Papai;
    • Van Ngoc, Tran;
    • Liu, Feng;
    • Scheuring, Urban;
    • Patel, Nikunj;
    • Peters, Solange;
    • Rizvi, Naiyer A.
    Publication type:
    Article
    27

    Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial.

    Published in:
    2018
    By:
    • Ramalingam, Suresh S.;
    • Pérol, Maurice;
    • Reck, Martin;
    • Kowalyszyn, Ruben Dario;
    • Gautschi, Oliver;
    • Kimmich, Martin;
    • Eun Kyung Cho;
    • Czyzewicz, Grzegorz;
    • Grigorescu, Alexandru;
    • Karaseva, Nina;
    • Dakhil, Shaker;
    • Pablo Lee;
    • Zimmerman, Annamaria;
    • Sashegyi, Andreas;
    • Alexandris, Ekaterine;
    • Carter, Gebra Cuyun;
    • Winfree, Katherine B.;
    • Garon, Edward B.;
    • Cho, Eun Kyung;
    • Lee, Pablo
    Publication type:
    journal article
    28
    29
    30

    Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation- Positive Metastatic Non—Small-Cell Lung Cancer.

    Published in:
    2017
    By:
    • Garon, Edward B.;
    • Reck, Martin;
    • Paz-Ares, Luis;
    • Ponce, Santiago;
    • Jaime, Jesus Corral;
    • Juan, Oscar;
    • Nadal, Ernest;
    • Lee, Pablo;
    • Dalai, Rita;
    • Jingyi Liu;
    • Shuang He;
    • Treat, Joseph;
    • Kazuhiko Nakagawa;
    • Dalal, Rita;
    • Liu, Jingyi;
    • He, Shuang;
    • Nakagawa, Kazuhiko
    Publication type:
    journal article
    31

    Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non-Small-Cell Lung Cancer.

    Published in:
    2015
    By:
    • Reynolds, Craig H;
    • Patel, Jyoti D;
    • Garon, Edward B;
    • Olsen, Mark R;
    • Bonomi, Philip;
    • Govindan, Ramaswamy;
    • Pennella, Eduardo J;
    • Liu, Jingyi;
    • Guba, Susan C;
    • Li, Shi;
    • Spigel, David R;
    • Hermann, Robert C;
    • Socinski, Mark A;
    • Obasaju, Coleman K
    Publication type:
    journal article
    32

    Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed- Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non-Small-Cell Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2015, v. 16, n. 3, p. 200, doi. 10.1016/j.cllc.2014.11.004
    By:
    • Reynolds, Craig H.;
    • Patel, Jyoti D.;
    • Garon, Edward B.;
    • Olsen, Mark R.;
    • Bonomi, Philip;
    • Govindan, Ramaswamy;
    • Pennella, Eduardo J.;
    • Jingyi Liu;
    • Guba, Susan C.;
    • Shi Li;
    • Spigel, David R.;
    • Hermann, Robert C.;
    • Socinski, Mark A.;
    • Obasaju, Coleman K.
    Publication type:
    Article
    33
    34

    Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists.

    Published in:
    Cancer Medicine, 2022, v. 11, n. 2, p. 530, doi. 10.1002/cam4.4459
    By:
    • Mileham, Kathryn F.;
    • Schenkel, Caroline;
    • Bruinooge, Suanna S.;
    • Freeman‐Daily, Janet;
    • Basu Roy, Upal;
    • Moore, Amy;
    • Smith, Robert A.;
    • Garrett‐Mayer, Elizabeth;
    • Rosenthal, Lauren;
    • Garon, Edward B.;
    • Johnson, Bruce E.;
    • Osarogiagbon, Raymond U.;
    • Jalal, Shadia;
    • Virani, Shamsuddin;
    • Weber Redman, Mary;
    • Silvestri, Gerard A.
    Publication type:
    Article
    35
    36
    37
    38
    39
    40

    Detecting HLA loss of heterozygosity within a standard diagnostic sequencing workflow for prognostic and therapeutic opportunities.

    Published in:
    NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00665-z
    By:
    • Lozac'hmeur, Ariane;
    • Danek, Tyler;
    • Yang, Qidi;
    • Rosasco, Mario G.;
    • Welch, John S.;
    • Go, William Y.;
    • Ng, Eric W.;
    • Mardiros, Armen;
    • Maloney, David G.;
    • Garon, Edward B.;
    • Kirtane, Kedar;
    • Simeone, Diane M.;
    • Molina, Julian R.;
    • Salahudeen, Ameen A.;
    • Stein, Michelle M.;
    • Hecht, J. Randolph
    Publication type:
    Article
    41
    42
    43
    44
    45